<p>(A) OASFs were incubated with HGF for indicated time intervals, mTORC1 and S6K phosphorylation was examined by Western blotting. (B–D) OASFs were pretreated for 30 min with rapamycin (30 nM) followed by treatment with HGF for 24 h, the VEGF-A expression was examined by qPCR, Western blotting, and ELISA. (E) OASFs were transfected with mTORC1 siRNA followed by stimulation with HGF for 24 h, the VEGF-A expression was examined by ELISA. (F) OASFs were pretreated for 30 min with c-Met inhibitor, Ly294002, and Akt inhibitor for 30 min, followed by stimulation with HGF for 30 min, and mTORC1 phosphorylation was determined by Western blotting. Results are expressed as the mean ± S.E. *, <i>p</i><0.05 compared with control; #, <i>p</i><0.05 comp...
<p><b>A:</b> Immunoblotting showing that treatment of normal endothelial cells (HDMEC) with exogenou...
<p>(<b>A</b>) Western blot analysis of EGFR and mTORC1 activation (S6K) in HFKs with stable expressi...
<p>A-H, Rapamycin lowers mTORC1 activity independent of presence of E2, ERα- or ERβ-agonist, however...
<p>OASFs were pretreated with c-Met inhibitor, Ly294002, Akt inhibitor, and rapamycin for 30 min (A)...
<p><i>A,</i> 786-0 cells were transfected with the 2.6-kb VEGF promoter-luciferase construct (0.5 µg...
<p>HUVECs were treated by rapamycin, two different small interfering RNAs against rictor (siRict<sup...
<p>(A) OASFs were incubated with HGF for indicated time intervals, and HIF-1α expression was examine...
<p>OASFs were incubated with HGF (3–100 ng/ml) for 24 h (A) or with HGF (30 ng/ml) for 6, 12, or 24 ...
Recent clinical trials using rapalogues in tuberous sclerosis complex (TSC) show regression in volum...
(a) Western blot analysis of WT and Vim −/− MEFs starved with RPMI media lacking amino acids, glucos...
<p>HUVECs were transfected with siRict<sup>1</sup> or siAkt1, then stimulated with 20 ng/mL VEGF for...
<p>Low levels of VEGFR1 in hemangioma endothelial cells result in constitutive VEGFR2 signaling and ...
<p>(A) The MDA-MB-231 cells were treated without or with various concentrations of T2A for 24 hours ...
Hemangiomas are tumors formed by hyper-proliferation of vascular endothelial cells. This is caused b...
Angiogenesis is essential for the progression of osteoarthritis (OA). Hepatocyte growth factor (HGF)...
<p><b>A:</b> Immunoblotting showing that treatment of normal endothelial cells (HDMEC) with exogenou...
<p>(<b>A</b>) Western blot analysis of EGFR and mTORC1 activation (S6K) in HFKs with stable expressi...
<p>A-H, Rapamycin lowers mTORC1 activity independent of presence of E2, ERα- or ERβ-agonist, however...
<p>OASFs were pretreated with c-Met inhibitor, Ly294002, Akt inhibitor, and rapamycin for 30 min (A)...
<p><i>A,</i> 786-0 cells were transfected with the 2.6-kb VEGF promoter-luciferase construct (0.5 µg...
<p>HUVECs were treated by rapamycin, two different small interfering RNAs against rictor (siRict<sup...
<p>(A) OASFs were incubated with HGF for indicated time intervals, and HIF-1α expression was examine...
<p>OASFs were incubated with HGF (3–100 ng/ml) for 24 h (A) or with HGF (30 ng/ml) for 6, 12, or 24 ...
Recent clinical trials using rapalogues in tuberous sclerosis complex (TSC) show regression in volum...
(a) Western blot analysis of WT and Vim −/− MEFs starved with RPMI media lacking amino acids, glucos...
<p>HUVECs were transfected with siRict<sup>1</sup> or siAkt1, then stimulated with 20 ng/mL VEGF for...
<p>Low levels of VEGFR1 in hemangioma endothelial cells result in constitutive VEGFR2 signaling and ...
<p>(A) The MDA-MB-231 cells were treated without or with various concentrations of T2A for 24 hours ...
Hemangiomas are tumors formed by hyper-proliferation of vascular endothelial cells. This is caused b...
Angiogenesis is essential for the progression of osteoarthritis (OA). Hepatocyte growth factor (HGF)...
<p><b>A:</b> Immunoblotting showing that treatment of normal endothelial cells (HDMEC) with exogenou...
<p>(<b>A</b>) Western blot analysis of EGFR and mTORC1 activation (S6K) in HFKs with stable expressi...
<p>A-H, Rapamycin lowers mTORC1 activity independent of presence of E2, ERα- or ERβ-agonist, however...